• CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Clinical and Laboratory Standards Institute , 03/01/2017

Publisher: CLSI

File Format: PDF

$90.00$180.00


This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

More Standards PDF

CSA ANSI Z21.86b-2007/CSA 2.32b-2007
CSA C22.2 NO. 178.1-07

CSA C22.2 NO. 178.1-07

$46.00 $92.00

CSA C22.2 NO. 41-07 (R2012)

CSA C22.2 NO. 41-07 (R2012)

$150.00 $300.00

CSA W48-06 (R2011)

CSA W48-06 (R2011)

$97.00 $195.00